Clene Inc.
Clene Inc. (CLNN): 5 pipeline candidates · ~5 mo cash runway · 5 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
5.4 months
D/E -2.15 · 0% dilution
Lead: Phase 2
5 candidates
N/A
1 buy · 49 sells (180d)
A transparent, data-derived signal for Clene Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$75.8M
Cash
$6.0M
Quarterly Burn
$4.5M
Runway
5.4 mo
Revenue
$15K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| cnm-agzn17 | Preclinical |
| cnm-au8 | Phase 2 |
| cnm-znag | Preclinical |
| cnmau8 | Phase 2 |
| gold nanocrystals | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
25
Total value held
$6.3M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 616,460 | $3.0M |
| scoggin management lp | 300,000 | $1.5M |
| geode capital management, llc | 95,874 | $473K |
| peak6 llc | 50,012 | $247K |
| vanguard fiduciary trust co | 43,715 | $216K |
| parsons capital management inc/ri | 37,243 | $184K |
| blackrock, inc. | 33,799 | $167K |
| state street corp | 29,801 | $147K |
| morgan stanley | 19,832 | $98K |
| northern trust corp | 16,143 | $80K |
Showing top 10 of 25 institutional holders of Clene Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Clene Inc.'s pipeline?
Clene Inc. (CLNN) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Clene Inc.'s lead drug candidate?
Clene Inc.'s most advanced tracked candidate is cnm-agzn17 (Preclinical) for Infectious diseases and wound/burn healing.
What is Clene Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Clene Inc. has approximately 5.4 months of cash runway.
What is Clene Inc.'s market capitalization?
Clene Inc.'s market capitalization is approximately $75.8M.
Who is the CEO of Clene Inc.?
Mr. Robert Etherington MBA is the chief executive officer of Clene Inc. (CLNN).
Get the full picture on Clene Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.